Matches in SemOpenAlex for { <https://semopenalex.org/work/W2581185180> ?p ?o ?g. }
- W2581185180 endingPage "115" @default.
- W2581185180 startingPage "115" @default.
- W2581185180 abstract "Abstract Introduction Rearrangements at 8q24 are seen in up to 47% of multiple myeloma (MM) patients by a combination of fluorescence in situ hybridization (FISH), spectral karyotyping and classical cytogenetics. The gene of interest in this region is MYC, a known oncogene which acts a transcription factor and is involved in various pathways including cell cycle progression, apoptosis and cellular transformation. In myeloma, activation of MYC may be mediated through copy number changes or translocations where B-cell super-enhancers are juxtaposed to MYC resulting in its over-expression. In 30% of samples the partner super-enhancer comes from an Ig loci, and in the remainder the super-enhancer comes from genes commonly associated with myeloma such as FAM46C, FOXO3, and XBP1. The nature and extent of MYC abnormalities in MM still remains debatable, with a range of abnormalities including deletions, trisomies, jumping MYC rearrangements and translocations. Here we identify the range of abnormalities, the clonality and partner chromosomes involved. Methods We conducted a systematic investigation using interphase FISH (iFISH), gene expression profiling (GEP), karyotyping, and targeted sequencing to determine the prevalence and genetic basis for MYC aberrations in groups of plasma cell disorders incorportating monoclonal gammopathy of undetermined significance (MGUS, n=97), smoldering MM (SMM, n=64), and newly diagnosed symptomatic MM (NDMM, n=307). Two FISH probes were used that are 1 Mb telomeric and centromeric of MYC, as well as a third probe targeting MYC itself. These were co-hybridized to cells from bone marrow aspirates. Translocations were defined where the MYC probe and an adjacent probe hybridized to another chromosome, whereas jumping translocations were defined where only the MYC probe hybridized to another chromosome. Cells were also analyzed for common IGH translocations, gain of 1q and del(17p) by FISH as well as common myeloma mutations and copy number abnormalities using a targeted sequencing panel. Results By iFISH, copy number variations of either loss or gain of the 8q24 region were present in 18.2% of NDMM; and structural aberrations including translocations and jumping MYC rearrangements were present in 28.5%. By karyotyping, the partner chromosomes of the MYC translocations included 1p, 1q, 2p, 4q, 5q, 6q, 14q, or 22q. The most frequent genomic rearrangement was translocations of MYC to chromosome 1 [t(1;8)]. Altogether, MYC alterations were detected in 54.8% of NDMM patients. As the disease stage progressed more MYC abnormalities were detected from MGUS to SMM to NDMM, especially translocations (0%, 0%, 13.4%) and jumping rearrangements (4.1%, 4.7%, 15.1%). Some MYC abnormalities were detected in MGUS and SMM samples, but they consisted of many different FISH signal patterns which were present in fewer than 20% of cells, indicating a heterogeneous population of subclonal cells at the early stages of myeloma development. These subclonal populations were present in 17% of MGUS samples and 23% of SMM samples. Using gene expression arrays, samples with translocations and jumping rearrangements had higher levels of MYC expression compared to samples without these variants. Those with monosomy of MYC had lower expression of MYC and those with a heterogeneous population of abnormal MYC signals showed no difference in expression compared to samples with no abnormal signal. These data indicate that jumping MYC rearrangements result in over-expression of MYC in the same way as translocations of 8q24. However, current commercial probe designs do not incorporate the MYC locus and instead label the surrounding region. These assays do not identify jumping MYC rearrangements and as a result under-estimate the frequency of MYC abnormalities in myeloma. Conclusion MYC abnormalities are present in 54.8% of NDMM samples and occur by a variety of mechanisms from copy number changes to translocations. MYC translocations and jumping rearrangements are associated with over-expression of MYC, driving pathogenesis of the disease. MYC translocations are not present in MGUS or SMM samples, indicating this is a key lesion mediating the progression of disease to a symptomatic state. Disclosures Davies: Celgene: Consultancy, Honoraria; Takeda: Consultancy, Honoraria; Janssen: Consultancy, Honoraria. Morgan:Bristol Meyers: Consultancy, Honoraria; Takeda: Consultancy, Honoraria; Janssen: Research Funding; Celgene: Consultancy, Honoraria, Research Funding; Univ of AR for Medical Sciences: Employment." @default.
- W2581185180 created "2017-02-03" @default.
- W2581185180 creator A5001958312 @default.
- W2581185180 creator A5011515629 @default.
- W2581185180 creator A5012932489 @default.
- W2581185180 creator A5015802614 @default.
- W2581185180 creator A5016246851 @default.
- W2581185180 creator A5034560778 @default.
- W2581185180 creator A5042546543 @default.
- W2581185180 creator A5065773774 @default.
- W2581185180 creator A5071448111 @default.
- W2581185180 creator A5087775484 @default.
- W2581185180 creator A5090044223 @default.
- W2581185180 date "2016-12-02" @default.
- W2581185180 modified "2023-09-30" @default.
- W2581185180 title "Translocations and Jumping Rearrangements at 8q24 Result in over-Expression of MYC and are Key Drivers of Disease Progression" @default.
- W2581185180 doi "https://doi.org/10.1182/blood.v128.22.115.115" @default.
- W2581185180 hasPublicationYear "2016" @default.
- W2581185180 type Work @default.
- W2581185180 sameAs 2581185180 @default.
- W2581185180 citedByCount "2" @default.
- W2581185180 countsByYear W25811851802017 @default.
- W2581185180 countsByYear W25811851802022 @default.
- W2581185180 crossrefType "journal-article" @default.
- W2581185180 hasAuthorship W2581185180A5001958312 @default.
- W2581185180 hasAuthorship W2581185180A5011515629 @default.
- W2581185180 hasAuthorship W2581185180A5012932489 @default.
- W2581185180 hasAuthorship W2581185180A5015802614 @default.
- W2581185180 hasAuthorship W2581185180A5016246851 @default.
- W2581185180 hasAuthorship W2581185180A5034560778 @default.
- W2581185180 hasAuthorship W2581185180A5042546543 @default.
- W2581185180 hasAuthorship W2581185180A5065773774 @default.
- W2581185180 hasAuthorship W2581185180A5071448111 @default.
- W2581185180 hasAuthorship W2581185180A5087775484 @default.
- W2581185180 hasAuthorship W2581185180A5090044223 @default.
- W2581185180 hasBestOaLocation W25811851801 @default.
- W2581185180 hasConcept C104317684 @default.
- W2581185180 hasConcept C111936080 @default.
- W2581185180 hasConcept C138626823 @default.
- W2581185180 hasConcept C142724271 @default.
- W2581185180 hasConcept C150194340 @default.
- W2581185180 hasConcept C153911025 @default.
- W2581185180 hasConcept C159654299 @default.
- W2581185180 hasConcept C163864487 @default.
- W2581185180 hasConcept C174475383 @default.
- W2581185180 hasConcept C18431079 @default.
- W2581185180 hasConcept C203014093 @default.
- W2581185180 hasConcept C2776364478 @default.
- W2581185180 hasConcept C2777250017 @default.
- W2581185180 hasConcept C2777542201 @default.
- W2581185180 hasConcept C2778042024 @default.
- W2581185180 hasConcept C2779134260 @default.
- W2581185180 hasConcept C3008058167 @default.
- W2581185180 hasConcept C30481170 @default.
- W2581185180 hasConcept C502942594 @default.
- W2581185180 hasConcept C524204448 @default.
- W2581185180 hasConcept C53226629 @default.
- W2581185180 hasConcept C542903549 @default.
- W2581185180 hasConcept C54355233 @default.
- W2581185180 hasConcept C71924100 @default.
- W2581185180 hasConcept C7602840 @default.
- W2581185180 hasConcept C86339819 @default.
- W2581185180 hasConcept C86803240 @default.
- W2581185180 hasConceptScore W2581185180C104317684 @default.
- W2581185180 hasConceptScore W2581185180C111936080 @default.
- W2581185180 hasConceptScore W2581185180C138626823 @default.
- W2581185180 hasConceptScore W2581185180C142724271 @default.
- W2581185180 hasConceptScore W2581185180C150194340 @default.
- W2581185180 hasConceptScore W2581185180C153911025 @default.
- W2581185180 hasConceptScore W2581185180C159654299 @default.
- W2581185180 hasConceptScore W2581185180C163864487 @default.
- W2581185180 hasConceptScore W2581185180C174475383 @default.
- W2581185180 hasConceptScore W2581185180C18431079 @default.
- W2581185180 hasConceptScore W2581185180C203014093 @default.
- W2581185180 hasConceptScore W2581185180C2776364478 @default.
- W2581185180 hasConceptScore W2581185180C2777250017 @default.
- W2581185180 hasConceptScore W2581185180C2777542201 @default.
- W2581185180 hasConceptScore W2581185180C2778042024 @default.
- W2581185180 hasConceptScore W2581185180C2779134260 @default.
- W2581185180 hasConceptScore W2581185180C3008058167 @default.
- W2581185180 hasConceptScore W2581185180C30481170 @default.
- W2581185180 hasConceptScore W2581185180C502942594 @default.
- W2581185180 hasConceptScore W2581185180C524204448 @default.
- W2581185180 hasConceptScore W2581185180C53226629 @default.
- W2581185180 hasConceptScore W2581185180C542903549 @default.
- W2581185180 hasConceptScore W2581185180C54355233 @default.
- W2581185180 hasConceptScore W2581185180C71924100 @default.
- W2581185180 hasConceptScore W2581185180C7602840 @default.
- W2581185180 hasConceptScore W2581185180C86339819 @default.
- W2581185180 hasConceptScore W2581185180C86803240 @default.
- W2581185180 hasIssue "22" @default.
- W2581185180 hasLocation W25811851801 @default.
- W2581185180 hasOpenAccess W2581185180 @default.
- W2581185180 hasPrimaryLocation W25811851801 @default.
- W2581185180 hasRelatedWork W1485036288 @default.
- W2581185180 hasRelatedWork W1531879063 @default.
- W2581185180 hasRelatedWork W1965198658 @default.
- W2581185180 hasRelatedWork W1980836896 @default.